Abstract
We have been asked to provide our evaluation of the available data concerning the role of herpes simplex viruses in human malignancies. Perhaps we can begin by stating a set of criteria which, if fulfilled, would satisfy us that a particular virus was the causative agent of a particular malignancy. These requirements will form the framework around which the topic will be developed. Of course, we do not wish to imply that these criteria are original or that the form in which we have stated them is unique. These criteria include the following points: (1) There should be some epidemiologic or biological association or link between the malignancy and the suspected virus; (2) Purified preparations of the virus should induce tumors in its natural host or a similar species, and the resulting tumors should be similar to naturally occurring ones; (3) Ideally, one might hope to find similar naturallyoccurring malignancies in other animals caused by similar viruses; (4) The virus should transform cells in culture, and transformed cells should induce tumors similar to naturally occurring ones, and conversely, tumor cells cultured in vitro should be similar to transformed cells; (5) It should be possible to prevent the malignancy by preventing infection with the suspected virus. Needless to say, the different criteria carry different weight, and fulfillment of the second or fifth criteria stated above would provide very strong evidence for an etiologic role of the virus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abrahams, P. J., Mulder, C., Warnaar, S. O., van de Voorde, A., van der Eb, A. J.: Transformation of primary rat kidney cells by fragments of simian virus 40 DNA. j. Virol. 16, 818–823 (1975)
Adam, E., Kaufman, R. H., Melnick, J. L., Levy, A.H., Rawls, W.E.: Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. III. Houston, Texas. Amer. J. Epidem. 96, 427–442 (1972a)
Adam, E., Sharma, S.D., Zeigler, O., Iwamoto, L., Melnick, J.L., Levy, A.H., Rawls, W.E.: Seroepidemiologic studies of herpesvirus type 2 and carcinoma of the cervix. II. Uganda. J. nat. Cancer Inst. 48, 65–72 (1972b)
Adam, E., Rawls, W.E., Melnick, J.L.: The association of herpesvirus type 2 infection and cervical carcinoma. Pre v. Med. 3, 122–141 (1974)
Adelusi, B., Osunkoya, B. O., Fabiyi, A.: Antibodies to herpesvirus type 2 in carcinoma of the cervix uteri in Ibadan, Nigeria. Amer. J. Obstet. Gynec. 123, 758–761 (1975)
Alexander, E. R.: Possible etiologies of cancer of the cervix other than herpesvirus. Cancer Res. 33, 1485–1496 (1973)
Anzai, T., Dreesman, G.R., Courtney, R.J., Adam, E., Rawls, W.E., Benyesh-Melnick, M.: Antibody to herpes simplex virus type 2 - induced nonstructural proteins in women with cervical cancer and in control groups. J. Nat. Cancer Inst. 45, 1051–1059 (1975)
Aurelian, L., Strandberg, J.D., Daves, H.J.: HSV-2 antigens absent from biopsied cervical tumor cells: A model consistent with latency. Proc. Soc. exp. Biol. (N.Y) 140, 404–408 (1972)
Aurelian, L., Davis, H.J., Julian, C.G.: Herpesvirus type 2–induced tumor-specific antigen in cervical carcinoma. Amer. J. Epidem. 98, 1–9 (1973)
Aurelian, L., Smith, M.E., Cornish, D.J.: IgM antibody to tumorassociated antigen (AG-4) induced by herpes simplex virus type 2: Its use in location of the antigen in infected cells. J. nat. Cancer Inst. 56, 417–477 (1976)
Aurelian, L., Strand, B. C.: Herpesvirus type 2–related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer. Cancer Res. 36, 810–829 (1976)
Bacchetti, S., Graham, F.: Transfer of gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA. Proc. Natl. Acad. Sci. USA 74, 1590–1595 (1977)
Benyesh-Melnick, M., Schaffer, P.A., Courtney, R.J., Esparza, J., Kinura, S.: Viral gene function expressed and detected by temperature-sensitive mutants of herpes simplex virus. Cold Spr. Harb. Symp. quant. Biol. 39, 731–746 (1974)
Black, F.L., Hierholzer, W.J., De Pinheiro, F., Evans, A.S., Woodall, J.P., Option, E.M., Emmons, I.E., West, B.S., Edsall, G., Downs, W.G., Wallace, G.D.: Evidence for persistence of infectious agents in isolated human populations. Amer. J. Epidem. 100, 230–250 (1974)
Blank, H., Haines, H. G.: Experimental human reinfection with herpes simplex virus. J. invest. Derm. 61, 223–225 (1973)
Boyd, A.L., Orme, T.W.: Transformation of mouse cells after infection with ultraviolet-irradiation-inactivated herpes simplex virus type 2. Int. J. Cancer 16, 526–538 (1975)
Catalano, L. W.Jr., Johnson, L.H.: Herpesvirus antibody and carcinoma in situ of the cervix. J. Amer. med. Ass. 277, 447–450 (1971)
Chadha, K. C., Munyon, W.: Presence of herpes simplex virus-related antigens in transformed L cells. J.Virol. 75, 1475–1486 (1975)
Christenson, B., Espmark, A.: Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of herpes simplex virus infected cells. Int. J. Cancer 77, 318–325 (1976)
Cellard, W., Thornton, H., Green, M.: Cells transformed by human herpesvirus type 2 transcribe virus-specific RNA sequences shared by herpesvirus type 1 and 2. Nature (New Biol.) 243, 264–266 (1973)
Coppleson, M., Reid, B., Pixley, E.: Preclinical Carcinoma of the Cervix Uteri. London: Permagon Press 1967
Darai, G., Munk, K.: Human embryonic lung cells abortively infected with herpesvirus hominis type 2 show some properties of cell transformation. Nature (New Biol.) 241, 268–269 (1973)
Davis, D.B., Kingsbury, D. T.: Quantitation of the viral DNA present in cells transformed by UV-irradiated herpes simplex virus. J. Virol. 77, 793–799 (1976)
Duff, R., Rapp, F.: Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2. J. Virol. 8, 469–477 (1971a)
Duff, R., Rapp, F.: Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nature (New Biol.) 233, 48–50 (1971b)
Duff, R., Rapp, F.: Oncogenic transformation of hamster embryo cells after exposure to inactivated herpes simplex virus type 1. J. Virol. 72, 209–217 (1973)
Duff, R., Rapp, F.: Quantitative assay for transformation of 3T3 cells by herpes simplex virus type 2. J.Virol. 75, 490–496 (1975)
Duff, R., Krender, J.W., Levy, B.M., Katz, M., Rapp, F.: Comparative pathology of cells transformed by herpes simplex virus type 1 or type 2. J. nat. Cancer Inst. 53, 1159–1164 (1974)
Epstein, M.I.: Epstein-Barr virus — Is it time to develop a vaccine program ? J. nat. Cancer Inst. 56, 697–700 (1976)
Freedman, R. S., Joosting, A. C., Ryan, J. T., Nkoni, S.: A study of associated factors, including genital herpes, in black women with cervical carcinoma in Johannesburg. S. Afr. med. J. 48, 1747–1752 (1974)
Frenkel, N., Roizman, B., Cassai, E., Nahmias, A.: A DNA fragment of herpes simplex 2 and its transcription in human cervical cancer tissue. Proc. nat. Acad. Sci. (Wash.) 69, 3784–3789 (1972)
Frenkel, N., Locker, H., Cox, B., Roizman, B., Rapp, F.: Herpes simplex virus in DNA in transformed cells; sequence complexity in five hamster cell lines and one derived hamster tumor. J.Virol. 18, 885–893 (1976)
Graham, F. L., van der Eb, A. J.: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456–467 (1973)
Graham, F.L., Veldhuisen, G., Wilkie, N. M.: Infectious herpesvirus DNA. Nature (New Biol.) 245, 265–266 (1973)
Graham, F.L., van der Eb, A. J., Heijneker, H.L.: Size and location of the transforming region in human adenovirus type 5 DNA. Nature (Lond.) 257, 687–691 (1974a)
Graham, F.L., Abrahams, P. J., Mulder, C., Heijneker, H.L., Warnaar, S.O.,De Vries, F.A.J., Fiers, W., van de Eb, A. J.: Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40. Cold Spr. Harb. Symp. quant. Biol. 39, 637–650 (1974b)
Hampar, B., Aaronson, S.A., Derge, J.G., Chakrabarty, M., Showalter, S.D., Dunn, C.Y.: Activation of an endogenous mouse type C virus by ultraviolet-irradiated herpes simplex virus types 1 and 2. Proc. Nat. Acad. Sci. (USA) 73, 646–650 (1976)
Hay, J., Moss, H., Halliburton, I.W.: Induction of deoxyribonucleic acid polymerase and deoxyribonuclease activities in cells infected with herpes simplex virus type 2. Biochem. J. 124, 64 (1971)
Hayward, G.S., Frenkel, N., Roizman, B.: Anatomy of herpes simplex virus DNA: Strain differences and heterogenity in the locations of restriction endonuclease cleavage sites. Proc. nat. Acad. Sci. (Wash.) 72, 1768–1772 (1975)
Hayward, G. S., Jacob, R.J., Wadsworth, S. C., Roizman, B.: Anatomy of herpes simplex virus DNA: Evidence for four populations of molecules that differ in the relative orientations of their long and short components. Proc. nat. Acad. Sci. (Wash.) 72, 4243–4247 (1975b)
Heyerdahl, T.O.: Type 1 and type 2 herpesvirus and abnormal cervical cytology. J. Irish med. Ass. 67, 445–447 (1974)
Hollinshead, A., Lee, O.B., McKelway, W., Melnick, J.L., Rawls, W.E.: Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera. Proc. Soc. exp. Biol. (N. Y) 141, 688–693 (1972)
Hollinshead, A. C., Lee, O., Chretian, P.B., Tarpley, J.L., Rawls, W.E., Adam, E.: Antibodies to herpesvirus nonvirion antigens in squamous carcinoma. Sci. 182, 713–715 (1973)
Hollinshead, A.C., Tarro, C.: Soluble membrane antigens of lip and cervical carcinomas: Reactivity with antibody for herpesvirus nonvirion antigens. Sci. 179, 698–700 (1973)
Hollinshead, A.C., Tarro, G., Chretian, P., Rawls, W.E.: Characterization of herpesvirus nonvirion antigens: Relation to squamous cell carcinomas. In: Viral Immunodiagnosis. Kurstak, E., Morisset, R. (eds.). New York: Academic Press, Inc., 1974, pp. 301–319
Hollinshead, A.C., Chretien, P.B., Lee, O.B., Tarpley, J.L., Kerney, S.E., Silverman, N.A., Alexander, J. C.: In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens. Cancer Res. 36, 821–828 (1976)
Huebner, R.J., Todaro, G.J.: Oncogenes of RNA tumor viruses as determinants of cancer. Proc. nat. Acad. Sci. (Wash.) 64, 1087–1094 (1969)
Hughes, R.G., Munyon, W.H.: Temperature-sensitive mutants of herpes simplex virus type 1 defective in lysis but not in transformation. J. Virol. 16, 275–283 (1975)
Jamieson, A.T., Gentry, G.A., Subak-Sharpe, J.H.: Induction of both thymidine and deoxycytidase kinase activity. J. gen. Virol. 24, 465–480 (1974)
Janda, Z., Kanka, J., Vonka, V., Svoboda, B.: A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia. Int. J. Cancer 12, 626–630 (1973)
Josey, W.E., Nahmias, A. J., Naib, Z. M.: The epidemiology of type 2 (genital) herpes simplex virus infections. Obstet. gynec. Surv. 27, 295–302 (1972)
Kao, C.L., Chen, Y.A., Tang, M.C., Wen, K.H., Hsia, S.: Association of herpes simplex type 2 virus with cervical cancer of the uterus. J. Formosan med. Asso. 73, 122–127 (1974)
Kawana, T., Yoshino, K, Kasamatsu, T.: Estimation of specific antibody to type 2 herpes simplex virus among patients with carcinoma of the uterine cervix. Gann. 65, 438–445 (1974)
Kessler, 1.1., Kulcar, Z., Rawls, W.E., Smerderl, S., Strand, M., Lilienfield, A.M.: Cervical cancer in Yugoslavia. I. Antibodies to genital herpesvirus in cases and controls. J. nat. Cancer Inst. 52, 369–376 (1974)
Kessler, 1.1.: Human cervical cancer as a venereal disease. Cancer Res. 36, 783–791 (1976)
Kimura, S., Flannery, V.L., Levy, B., Schaffer, P. A.: Oncogenic transformation of primary hamster cells by herpes simplex virus type 2 (HSV-2) and an HSV-2 temperature-sensitive mutant. Int. J. Cancer 15, 786–798 (1975)
Kimura, S., Esparsa, J., Benyesh-Melnick, M., Schaffer, P.A.: Enhanced replication of temperature-sensitive mutants of HSV-type 2 at the nonpermissive temperature in cells transformed by HSV-2 Intervirology 3, 162–169 (1974)
Kit, S., Dubbs, D.R.: Acquisition of thymidine kinase activity by herpes simplex infected mouse fibroblast cells. Biochem. biophys. Res. Commun. 11, 55–59 (1963)
Kit, S., Leung, W. C., Jorgensen, G.N., Trkula, D., Dubbs, D.R.: Thymidine kinase isozymes of normal and virus-infected cells. Cold Spr. Harb. Symp. quant. Biol. 39, 703–716 (1974)
Kutinova, L., Vonka, V., Broucek, J.: Increased oncogenicity and synthesis of herpesvirus antigens in hamster cells exposed to herpes simplex type-2 virus. J. nat. Cancer Inst. 50, 759–766 (1973)
Li, J.L., Jerkofsky, M.A., Rapp, F.: Demonstration of oncogenic potential of mammalian cells transformed by DNA-containing viruses following photodynamic inactivation. Int. J. Cancer 15, 190–202 (1975)
Littlefield, J. W.: Selection of hybrids from matings of fibroblasts in vitro and their presumed recominants. Sci. 145, 709–710 (1964)
Lowry, S.P., Breswick, E., Rawls, W.E.: Differences in thymidine kinase-inducing ability of herpesvirus type 1 and 2. Virology 46, 958–961 (1971)
Macnab, J. C. M.: Transformation of rat embryo cells by temperature-sensitive mutants of HSV. J. gen. Virol. 24, 143–153 (1974)
Macnab, J.C.M.: Transformed cell lines produced by temperature-sensitive mutants of herpes simplex types 1 and 2. In: Second Int. Symp. Oncogenesis and Herpesviruses II. De-The, G., Epstein, M.A., and zur Hausen, H. (eds.). Switzerland, IARC Scientific Publications, 227–235 (1975)
Macnab, J. C. M., Timbury, M. C.: Complementation of ts mutants by a herpes simplex virus ts-transformed cell line. Nature (Lond.) 261, 233–235 (1976)
McAuslan, B.R.: Virus-associated enzymes. Life Sci. 14, 2083–2097 (1974)
McClung, H., Seth, P., Rawls, W.E.: Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of herpes simplex virus types 1 and 2. Amer. J. Epidem. 104, 192–201 (1977)
McDonald, A.D., Williams, M. C., Manfreda, J., West, R.: Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia. Amer. J. Epidem. 100, 130–135 (1974)
Melnick, J.L., Courtney, R.J., Powell, K.L., Schaffer, P. A., Benyesh-Melnick, M., Dreesman, G.R., Anzai, T., Adam, E.: Studies on herpes simplex virus and cancer. Cancer Res. 36, 845–856 (1976)
Menczer, J., Leventon-Kriss, S., Modan, M., Oelsner, G., Gerichter, C. B.: Antibodies to herpes simplex virus in Jewish women with cervical cancer and in healthy Jewish women of Israel. J. nat. Cancer Inst. 55, 3–6 (1975)
Munk, W., Darai, G.: Human embryonic lung cells transformed by HSV. Cancer Res. 33, 1535–1538 (1973)
Munoz, N.: Effect of herpesvirus type 2 and hormonal imbalance on the uterine cervix of the mouse. Cancer Res. 33, 1504–1508 (1973)
Munoz, N., De-The, G., Aristzabal, N., Yee, C., Rabson, A., Pearson, G.: Antibodies to herpesviruses in patients with cervical cancer and controls. In: Second Int. Symp. Oncogenesis and Herpesviruses II. Dt-The, G., Epstein, M.A., and zur Hausen, H. (eds.). Switzerland, IARD Scientific Publications, 45–51 (1975)
Munyon, W., Kraiselburd, E., Davies, D., Mann, J.: Transfer of thymidine kinase to thymidine kinaseless L cells by infection with ultraviolet-irradiated herpes simplex virus. J. Virol. 1, 813–820 (1971)
Nahmias, A. J., Josey, W.E., Naib, Z.M., Luce, C.F., Guest, B.: Antibodies to herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer. Amer. J. Epidem. 91, 547 (1970a)
Nahmias, A. J., Naib, Z. M., Josey, W. E., Murphy, F. A., Luce, C. F.: Sarcomas after inoculation of newborn hamsters with herpesvirus hominis type 2 strains. Proc. Soc. exp. Biol. (N. Y.) 134, 1065–1069 (1970b)
Nahmias, A. J., Naib, Z.M., Josey, W.E., Franklin, E., Jenkins, R.: Prospective studies of the association of genital herpes simplex infection and cervical anaplasia. Cancer Res. 33, 1491–1497 (1973)
Nahmias, A. J., Roizman, B.: Infection with herpes simplex viruses 1 and 2. New Engl. J. Med. 289, 661–614; 719–725; 781–789 (1973)
Nahmias, A.J., Naib, Z.M., Josey, W.E.: Epidemiological studies relating genital herpetic infections to cervical carcinoma. Cancer Res. 34, 1111–1147 (1974)
Nahmias, A.J., Del Buono, I., Ibrahim, I.: Antigenic relationship between herpes simplex viruses, human cervical cancer and HSV-associated hamster tumours. In: Second Int. Symp. Oncogenesis and Herpesviruses II. De-The, G., Epstein, M.A., and zur Hausen, H. (eds.). Switzerland, IARC Scientific Publications, 309–313 (1975)
Naib, Z.M., Nahmias, A. J., Josey, W.E., Zaki, S.A.: Relation of cytohistopathology of genital herpesvirus infections to cervical anaplasia. Cancer Res. 33, 1452–1463 (1973)
Notter, M.F.D., Docherty, J.J.: Comparative diagnostic aspects of herpes simplex virus tumor-associated antigens. J. nat. Cancer Inst. 1976
Oriel, J.D., Hayward, A.H.S.: Sexually-transmitted diseases in animals. Brit. J. vener. Dis. 50 (6), 417–420 (1974)
Ory, H., Conger, B., Ricbart, R., Barron, R.: Relation to type 2 herpesvirus antibodies to cervical neoplasia. Barbados, West Indies, 1971. Obstet. and Gynec. 43, 901–904 (1974)
Ory, H.W., Jenkins, R., Byrd, J.Y., Nahmias, A. J., Tyler, C.W., Allen, D.T., Conger, S.B.: The epidemiology and interrelationships of cervical dysplasia and type 2 herpesvirus in a low-income housing project. Amer. J. Obstet. Gynec. 123, 269–21A (1975)
Pagano, J. S.: Disease and mechanisms of persistent DNA virus infection: Latency and cellular transformation. J. infect. Dis. 132, 209–223 (1975)
Palencia, P.G., London, W.T., Nahmias, A. J., Naib, Z.M., Tunca, J., Fyccillo, D.A., Ellenberg, J.H., Sever, J.L.: A preliminary report on investigation of oncogenic potential of herpes simplex virus type 2 in Cebus monkey. Cancer Res. 36, 807–809 (1976)
Pada, M.R., Kummerlander, L., Pejtsik, B., Pali, K.: Herpesvirus antibodies and antigens in patients with cervical anaplasia and in controls. J. nat. Cancer Inst. 55, 775–781 (1975)
Peltonen, R.: Antibodies to herpesvirus hominis types 1 and 2 among women with neoplastic changes of uterine cervix. Acta obstet. gynec. scand. 54, 369–372 (1975)
Plummer, G.: A review of the identification and titration of antibodies to herpes simplex viruses types 1 and type 2 in human sera. Cancer Res. 33, 1469–1476 (1973)
Plummer, G., Master son, J.G.: Herpes simplex virus and carcinomp of the cervix. Amer. J. Obstet Gynec. 3, 81–84 (1971)
Rapp, F., Falk, L.A.: Study of virulence and tumorigenicity of varipnts of herpes simplex virus. Proc. Soc. exp. Biol. (N.Y.) 116, 361–365 (1964)
Rapp, F., Duff, R.: Transformation of hamster embryo fibroblasts by herpes simplex virus type 1 and type 2. Cancer Res. 33, 1527–1534 (1973)
Rapp, F., Li, J. L. H., Jerkofsky, M.: Transformation of mammalian cells by DNA-containing viruses following photodynamic inactivation. Virology 55, 339–346 (1973)
Rapp, F.: Herpesviruses and cancer. Advanc. Cancer Res. 19, 265–302 (1974)
Rapp, F., Li, J. L. H.: Demonstration of the oncogenic potential of herpes simplex viruses and human cytomegalovirus. Cold Spr. Harb. Symp. quant. Biol. 39, 747–763 (1975)
Rawls, W.E., Tompkins, W.A.F., Melnick, J.L.: The association of herpesvirus type 2 and carcinoma of the uterine cervix. Amer. J. Epidem. 89, 547 (1969)
Rawls, W. E., Adam, E., Melnick, J. L.: Geographic variations in the association of antibodies to herpesvirus type 2 and carcinoma of the cervix. In: Oncogenesis and Herpesviruses. De-The, G., Biggs, P. M., and Payne, L. N. (eds.). Lyon, France, IARC Scientific Publications, 424–427 (1972)
Rawls, W.E., Gardner, H.L.: Herpes genitalis: Venereal aspects. Clin. Obstet. Gynec. 15, 912–918 (1972)
Rawls, W.E., Adam, E., Melnick, J.L.: An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix. Cancer Res. 33, 1477–1490 (1973)
Rawls, W.E., Garfield, C.H., Seth, P., Adam, E.: Serological and epidemiological considerations of the role of herpes simplex virus type 2 in cervical cancer. Cancer Res. 36, 829–835 (1976)
Rotkin, I. D.: A comparison review of key epidemiological studies in cervical cancer related to current seaches for transmissible agents. Cancer Res. 33, 1353–1367 (1973)
Royston, I., Aurelian, L.: The association of genital herpesvirus with cervical atypia and carcinoma in situ. Amer. J. Epidem. 91, 531–538 (1970a)
Royston, I., Aurelian, L.: Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma. Proc. nat. Acad. Sci. (Wash.) 67, 204 (1970b)
Sabin, A.B., Tarro, G.: Herpes simplex and herpes genitalis viruses in etiology of some human cancers. Proc. nat. Acad. Sci. (Wash.) 70, 3225–3229 (1973)
Sabin, A.B.: Herpes simplex-genitalis virus nonvirion antigens and their implication in certain human cancers: unconfirmed. Proc. nat. Acad. Sci. (Wash.) 71, 3248–3252 (1974)
Schneweis, K.E., Haag, A., Lehmkoster, A., Kaenig, V.: Seroimmunological investigations in patients with cervical cancer: Higher rates of HSV-2 antibodies than in syphilis patients and evidence of IgM antibodies to an early HSV-2 antigen. In: Incogenesis and Herpesvirus II. De-The, G., Epstein, M.A., and zur Hausen, H. (eds.). Switzerland, IARC Scientific Publications, 53–57 (1975)
Schulte-Holthausen, H.: Persistence of herpesvirus DNA. In: Third Int. Congress for Virology. Madrid, 1975, p. 120.
Seth, P., Rawls, W.E., Duff, R., Rapp, F., Adam, E., Melnick, J.L.: Antigenic differences between isolates of herpesvirus type 2. Intervirology 3, 1–14 (1974)
Sever, J.L.: Herpesvirus and cervical cancer studies in experimental animals. Cancer Res. 33, 1509–1510 (1973)
Silverman, N.A., Alexander, J. C.Jr., Hollinshead, A.C., Chretian, P. B.: Correlation of tumor burden with in vitro lymphocyte reactivity and antibodies to herpesvirus tumor-associated antigens in head and neck squamous carcinoma. Cancer (Philad.) 37, 135–140 (1976)
Share, J., Summers, W.P., Summers, W.C.: Structure and function of herpesvirus genomes. I. Comparison of five HSV-1 and two HSV-2 strains by cleavage of their DNA with Eco R I restriction endonuclease. J. Virol. 15, 726–732 (1975)
Skinner, G.R.B., Thouless, M.E., Jordan, J. A.: Antibodies to type 1 and type 2 herpesvirus in women with abnormal cervical cytology. J. Obstet. Gynec. Brit. Commonw. 78, 1031–1038 (1971)
Skinner, G.R.B., Taylor, J., Edwards, J.: Precipitating antibodies to herpes simplex virus in human sera: Prevalence of antibody to common antigen (Band II). Intervirology 4, 320–324 (1974)
Smith, J. W., Adam, E., Melnick, J. L., Rawls, W. E.: Use of the 51Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2. J. Immunol. 109, 554–564 (1972)
Sprecher-Goldberger, S., Thiry, L., Cattoor, J.P., Hooghe, R., Pestcan, J.: Herpesvirus type 2 infection and carcinoma of the cervix. Lancet 2, 266 (1970)
Sprecher-Goldberger, S., Thiry, L., Gould, L, Fassin, Y., Gompel, C.: Increasing antibody titers to herpes simplex virus type 2 during follow-up women with cervical dysplasia. Amer. J. Epidem. 97, 103–110 (1973)
Steinhart, W.L., Grafstrom, R.H., Hill, C.W.: Terminal fragments of herpes simplex virus DNA produced by restriction endonuclease. Biochem. biophys. Res. Commun. 67, 556–561 (1975)
Takahashi, M., Yamanishi, K.: Transformation of hamster embryo and human embryo cells by temperature-sensitive mutants of herpes simplex virus type 2. Virology 61, 306–311 (1974)
Thiry, L., Sprecher-Goldberger, S., Fassin, Y., Gould, I., Compel, C., Pestiau, J.,DeHalleux, F.: Variations of cytotoxic antibodies to cells with herpes simplex antigens in women with proatessing or regressing cancerous lesions of the cervix. Amer. J. Epidem. 100, 251–561 (1974)
Thouless, M. E.: Serological properties of thymidine kinase produced in cells infected with type 1 or type 2 herpes virus. J. gen. Virol. 17, 307–315 (1972)
Trentin, J. J., Van Hoosier, G.L., Boren, Ferguson, D.G., Kitamura, I.: Oncogenic evaluation in hamsters of human picorna-, paramyxo-, and herpesviruses. Soc. exp. Biol. (N.Y.) 132, 912–915 (1969)
Vestgaard, B.F., Hornsleth, A., Pedersen, S.N.: Occurrence of herpes and adenovirus antibodies in patients with carcinoma of the cervix uteri. Cancer (Philad.) 30, 68–74 (1972)
Weissbach, A., Hong, S.C.L., Aucker, J.. Muller, R.: Characterization of herpes simplex virus-induced deoxyribonucleic acid polymerase. J. biol. Chem. 248, 6270–6277 (1973)
Wentz, W. B., Reagan, J. W., Heggie, A.D.: Cervical carcinogenesis with herpes simplex virus type 2. Obstet. and Gynec. 46, 117–121 (1975)
Wilkie, N.M., Clements, J.B., Macnab, J.C.M., Subak-Sharpe, J.H.: The structure and biological properties of herpes simplex virus DNA. Cold Spr. Harb. Symp. quant. Biol. 39, 657–666 (1974)
Zur Hausen, H., Schulte-Holthausen, H., Wolf, H., Dorries, K., Egger, H.: Attempts to detect virus-specific DNA in human tumors. II. Nucleic acid hybridizption with complementary RNA of human herpes group viruses. Int. J. Cancer. 13, 657–664 (1974)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Rawls, W.E., Bacchetti, S., Graham, F.L. (1977). Relation of Herpes Simplex Viruses to Human Malignancies. In: Arber, W., et al. Current Topics in Microbiology and Immunology. Current Topics in Microbiology and Immunology, vol 77. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66740-4_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-66740-4_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66742-8
Online ISBN: 978-3-642-66740-4
eBook Packages: Springer Book Archive